Date: August 5, 2026

Financial Performance Overview

Inventurus Knowledge Solutions Limited (IKS Health) announced its standalone and consolidated financial results for the quarter ended June 30, 2026 (Q1 FY27). The company reported strong growth across key financial metrics.

Key Financial Highlights

Revenue: INR 8,936 Million, representing a 20.7% year-over-year (YoY) growth.

EBITDA: INR 2,949 Million, representing a 24% YoY growth. The EBITDA margin was 33% of revenue.

Profit After Tax (PAT): INR 1,937 Million, representing a 27.8% YoY growth. The PAT margin was 21.7% of revenue.

Adjusted PAT: INR 2,153 Million, representing a 28.0% YoY growth. The Adjusted PAT margin was 24.1% of revenue.

Currency Performance: Revenue growth was 12% YoY when measured in USD.

Management Commentary

Sachin K. Gupta, Founder & Global CEO, attributed the strong results to the resilience of the business model, client trust, operational efficiency, and a scalable care enablement platform. He highlighted a decade of profitable growth with an impressive 46% PAT CAGR. He stated that the acquisition of TruBridge is an important milestone that expands the company's capabilities and strengthens its ability to serve a broader range of healthcare organizations, including rural and community health systems.

Nithya Balasubramanian, Group CFO, stated that the robust results were a direct result of a focus on cost discipline, platform scalability, and capital efficiency. The priority for the rest of the fiscal year is to protect margins while investing prudently in strategic capabilities for long-term value.

Business Overview and Recognition

IKS Health is a global healthcare technology company that partners with health systems, physician groups, specialty practices, and rural and community hospitals. Its platform integrates agentic AI workflows with human expertise to improve operational efficiency, financial sustainability, and care delivery.

The company received several notable recognitions in the quarter:

  • A U.S. patent was granted for its proprietary AI-driven Engagement Learning Engine, which powers patient access solutions.
  • Sachin K. Gupta was named a 2026 Dallas-Fort Worth Titan 100 CEO.
  • Won the 'Excellence in Investor Relations' award (organizational category) and 'Best CFO in Healthcare' award for Nithya Balasubramanian (individual category) at the Best CFO & Finance Strategy Excellence Awards 2026.
  • Won the 'Excellence in Onboarding and Role Enablement' award at the FE HR Awards 2026.
  • Received the Distinguished Corporate Partner Award 2026 from the American Medical Group Association (AMGA).

Corporate Details

Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India.

The company was listed on the NSE and BSE on December 19, 2024.

Contacts

Media Contact: Sameer Arora, Senior Vice President (press@ikshealth.com)

Investor Relations Contact: Saransh Mundra, Head - Investor Relations (investor_relations@ikshealth.com)